Target Healthcare REIT (LON:THRL) Sets New 52-Week High – Time to Buy?

Target Healthcare REIT (LON:THRLGet Free Report)’s share price hit a new 52-week high during mid-day trading on Monday . The stock traded as high as GBX 113 and last traded at GBX 110.60, with a volume of 34288 shares trading hands. The stock had previously closed at GBX 110.76.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group restated a “hold” rating and set a GBX 101 price objective on shares of Target Healthcare REIT in a report on Wednesday, May 6th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, Target Healthcare REIT has an average rating of “Hold” and an average price target of GBX 101.

Read Our Latest Research Report on THRL

Target Healthcare REIT Stock Performance

The business has a 50 day moving average of GBX 107.43 and a 200-day moving average of GBX 104.61. The company has a market capitalization of £689.95 million, a P/E ratio of 8.85, a price-to-earnings-growth ratio of 1.48 and a beta of 0.70.

Target Healthcare REIT Company Profile

(Get Free Report)

Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.

Read More

Receive News & Ratings for Target Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Target Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.